Results 1 to 10 of about 632,366 (296)

Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study

International Journal of Endocrinology, 2022
Introduction. Papillary thyroid cancer (PTC) is one of the most prevalent endocrine malignancies that has increased in recent decades around the world.
Liu Yihao, Li Shuo, Xi Pu, Wang Zipeng, Sun Hanlin, Chang Qungang, Wang Yongfei, Yin Detao   +7 more
doaj   +1 more source

The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population

International Journal of Endocrinology, 2022
Background. The BRAF V600E mutation is an important genetic event in papillary thyroid cancer (PTC). This study aimed to provide additional information regarding the association of the BRAF V600E mutation with PTC prognosis. Methods.
Ziheng Ye, Xiaotian Xia, Peipei Xu, Wenfei Liu, Shoufei Wang, Youben Fan, Minggao Guo   +6 more
doaj   +1 more source

Practice patterns and outcomes in the management of Thai patients with Graves’ disease

Thyroid Research, 2021
Background The treatment of hyperthyroid Graves’ disease (GD) varies considerably among geographic areas. In this study, we aimed to evaluate practice patterns and treatment outcomes in Thai patients with hyperthyroid GD.
Yotsapon Thewjitcharoen, Krittadhee Karndumri, Waralee Chatchomchuan, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanathayanoroj, Nampetch Lekpittaya, Worawit Kittipoom, Tawee Anuntakulnatee, Somboon Vongterapak, Siriwan Butadej, Soontaree Nakasatien, Rajata Rajatanavin, Thep Himathongkam   +13 more
doaj   +1 more source

Transcription Factor E2F1 Exacerbates Papillary Thyroid Carcinoma Cell Growth and Invasion via Upregulation of LINC00152

Analytical Cellular Pathology, 2022
Background. Papillary thyroid carcinoma (PTC) is the most common thyroid neoplasm, whereas transcription factor E2F1 has been previously implicated in PTC progression.
Junjie Yang, Yong Ying, Xiangtai Zeng, Jiafeng Liu, Yang Xie, Zefu Deng, Zhiqiang Hu, Zanbin Li   +7 more
doaj   +1 more source

A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets

Journal of Immunology Research, 2022
Yin-Yang 1 (YY1) has a crucial function in the development of several malignancies, according to recent research. However, nothing is known about its aberrant expression and prognostic significance in human pan-cancer.
Xinghao Fu, Feihong Ji, Qi He, Xinguang Qiu   +3 more
doaj   +1 more source

Changing the patterns of hospitalized diabetic foot ulcer (DFU) over a 5-year period in a multi-disciplinary setting in Thailand

BMC Endocrine Disorders, 2020
Background After years of decline, the rate of amputations was reported to increase by 50% in the U.S. population between 2009 and 2015. Few studies have examined the most recent trends in hospitalized diabetic foot ulcer (DFU) in Asian patients.
Yotsapon Thewjitcharoen, Jeeraphan Sripatpong, Sirinate Krittiyawong, Sriurai Porramatikul, Taweesak Srikummoon, Somkiet Mahaudomporn, Siriwan Butadej, Soontaree Nakasatien, Thep Himathongkam   +8 more
doaj   +1 more source

Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study

The Breast Journal, 2022
Background. Estrogen and progesterone receptor status can predict breast cancer patient prognosis and treatment sensitivity, but research on low ER and PR levels and expression balance remains limited. Methods.
Jin Liu, Mingyu Gan, Zijing Lin, Qin Deng, Juan Deng, Bin Zeng, Yanling Shi, Jia Ming   +7 more
doaj   +1 more source

Recurrence Factors and Characteristic Trends of Papillary Thyroid Cancer over Three Decades

International Journal of Endocrinology, 2021
Background. The prevalence of thyroid cancer is rising worldwide. Although thyroid cancer has a favorable prognosis, up to 20% of patients experienced recurrent disease during the follow-up period.
Waralee Chatchomchuan, Yotsapon Thewjitcharoen, Krittadhee Karndumri, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Somboon Vongterapak, Siriwan Butadej, Veekij Veerasomboonsin, Auchai Kanchanapitak, Rajata Rajatanavin, Thep Himathongkam   +11 more
doaj   +1 more source

Exploration of Hub Genes and Pathogenetic Pathways in Systemic Lupus Erythematosus Complicated with Early Onset Atherosclerosis

Mediators of Inflammation, 2023
Background. Notwithstanding the mounting evidence to suggest that systemic lupus erythematosus (SLE) accelerates the progression of atherosclerosis, the mechanisms underlying this phenomenon are yet to be completely understood. This research examined the
Han Zhang, Yinde Huang, Xin Li, Wenbin Chen, Yu Lun, Jian Zhang   +5 more
doaj   +1 more source

Identifying Hub Genes and Immune Cell Infiltration for the Progression of Carotid Atherosclerotic Plaques in the Context of Predictive and Preventive Using Integrative Bioinformatics Approaches and Machine-Learning Strategies

Journal of Immunology Research, 2022
Emerging evidence shows that carotid atherosclerosis is related to the activation of immune-related pathways and inflammatory cell infiltration. However, the immune-linked pathways that helped in the advancement of the carotid atherosclerotic plaque and ...
Han Zhang, Yinde Huang, Xin Li, Wenbin Chen, Yu Lun, Jian Zhang   +5 more
doaj   +1 more source